Lung Cancer Animation

Allos Therapeutics Announces Topline Results From Phase 2b Study Of FOLOTYN In Patients With Advanced Non-Small Cell Lung Cancer
Allos Therapeutics, Inc. (NASDAQ:ALTH) announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen...

NICE Recommends Two New Cancer Drugs This Month
In final guidance published today, NICE is pleased to be able to recommend two new treatments; for inoperable advanced gastric cancer and for non small cell lung cancer...

Circulating Aberrant Cells Increase As Non-Small Cell Lung Cancer Progresses
A novel approach detects genetically abnormal cells in the blood of non-small cell lung cancer patients that match abnormalities found in tumor cells and increase in number with the severity of the disease, a research team led by scientists at The University of Texas MD Anderson Cancer Center report in the journal Clinical Cancer Research...

Faster Tracking Of Lung Tumors May Help Treatment
Today, at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, a group of researchers from Stanford University will describe the latest developments toward their goal of integrating two existing medical devices -- medical linear accelerators, or "linacs," which produce powerful X-rays for treating cancer, and magnetic resonance i...

Geron Initiates Randomized Phase 2 Clinical Trial Of Imetelstat In Non-Small Cell Lung Cancer
Geron Corporation (Nasdaq:GERN) announced enrollment of the first patient in a randomized Phase 2 clinical trial of its telomerase inhibitor drug, imetelstat (GRN163L), as maintenance therapy following platinum-based induction therapy for patients with non-small cell lung cancer (NSCLC)...

Personalized Medicine For Lung Cancer More Likely With New Method Of Tissue Banking
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect...

Spanish Study Analyzes The Probability Of Surviving Nine Types Of Cancer
"The innovative factor contributed by our work is its relevance to population and measurement of relative survival, which enables us to discover survival related to cancer in a more precise way", María Dolores Chirlaque, main author of the study and researcher in the Epidemiology Service of the Department of Health and Consumption in Murcia, explains to SINC...

Study Reveals Canadians Living With Lung Cancer Are Too Often Stigmatized
Canadian lung cancer patients are likely to suffer significant stigma due to the disease's link to smoking, a connection that may impact the care and treatment patients receive...

Leading Cancer Hospital Becomes First In India To Offer Stereotactic Lung Radiosurgery Treatments Using Varian's RapidArc(R) Technology
A 65-year-old man with inoperable lung cancer has become the first lung cancer patient in India to receive stereotactic radiosurgery, a promising new approach for treating this disease. Doctors at Yashoda Hospital in Hyderabad were able to deliver the treatment using RapidArc technology from Varian Medical Systems (NYSE: VAR)...

Optics Express Publishes Special Focus Issue Highlighting Lung Cancer Imaging Research
Advanced imaging technologies that promise to improve the development of effective drugs to treat lung cancer are the focus of the current special issue of Optics Express, an open-access journal published by the Optical Society (OSA)...

Lung Cancer Models Show That Cancer Stem Cells Are Not One Size Fits All
Cancer stem cells have enticed scientists because of the potential to provide more durable and widespread cancer cures by identifying and targeting the tumor's most voracious cells...

Response Genetics Launches EML4-ALK Genetic Test In Lung Cancer
Response Genetics Inc. (Nasdaq: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, announced that it has expanded its ResponseDX: Lung™ genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about four percent of tumors from patients with non-small cell lung cancer (NSCLC)...

Commission On Cancer Launches National Pilot Study For Expansion Of Geisinger Health System's Provencare Methodologies In Select Lung Cancer Patient
A national pilot study that will promote evidence-based evaluation and treatment standards for patients with resectable non small cell lung cancer (NSCLC) was launched yesterday by the Commission on Cancer (CoC) of the American College of Surgeons...

How Asbestos Causes Cancer: Mystery Unraveled
More than 20 million people in the U.S., and many more worldwide, who have been exposed to asbestos are at risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen that is resistant to current therapies. Moreover, asbestos exposure increases the risk of lung cancer among smokers...

Oncimmune(R) EarlyCDT-LungTM -- A Simple Blood Test To Aid In The Early Detection Of Lung Cancer -- Now Available In Canada
Oncimmune LLC, provider of EarlyCDT-Lung, a simple physician-ordered blood test that aids physicians in the risk assessment and early detection of lung cancer in high-risk patients, most notably long-term smokers or former smokers, today announced that the test is now commercially available in Canada after receiving strong interest from Canadian physicians at the American Colle...